ApoVax, Inc. — Form D
ApoVax, Inc. of LOISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-28. The offering totals $1.7M, of which $25K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-01-28
- Form: D
- Accession: 0000911959-11-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.7M
- Amount sold: $25K
- Remaining: $1.7M
- Investors: 1
- Date of first sale: 2011-01-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-154523
Issuer
- Name: ApoVax, Inc.
- CIK: 0001329338
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1044 EAST CHESTNUT ST, LOISVILLE, KY, 40204
- Phone: 502-212-2493
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Haval R Shirwan | Director | Louisville, KY |
| Haval J Shirwan | Director | Louisville, KY |
| Haval J Shirwan | Executive Officer | Louisville, KY |
| George R Emont | Director | Louisville, KY |
| George R Emont | Executive Officer | Louisville, KY |
| Michael J Curtin | Director | Louisville, KY |
| Steven R Gailar | Director | Louisville, KY |
| Steven R Gailar | Executive Officer | Louisville, KY |
Other filings by this issuer (2)
More